Velarion Records
Free. Unsubscribe any time.

BioXcel Therapeutics, Inc. (BTAI)

BioXcel Therapeutics, Inc. filed 4 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 4 reporting owners, covering 4 transactions and 39,669 shares. None carries the SEC's AFF10B5ONE flag; all 4 name a plan in a footnote. No results print is on file in this window, so no interval is measured.

What stands out

Trades in BioXcel Therapeutics, Inc. 4

Adoption dates in BioXcel Therapeutics, Inc. 1

Results prints in BioXcel Therapeutics, Inc. 0

Trades before a print in BioXcel Therapeutics, Inc. 0

Interval to BioXcel Therapeutics, Inc.’s next reported results date

How the interval and sources are counted →

Adoption dates BioXcel Therapeutics, Inc. states

Filing text: “10b5-1 trading plan adopted by the reporting person on February 3, 2026”

Sources: SEC EDGAR full-text search and the SEC submissions API.